PS29MRCdic identifies patients with AML with inferior prognosis. Kaplan-Meier curve showing outcomes of patients according to the PS29MRC risk groups. (A) Outcomes of all patients. (B) Outcomes of patients younger than 60 years. (C) Outcomes of patients ≥60 years of age. (D) Comparison of patients with TP53 mutations and patients without a TP53 mutation, but with high PS29MRC values (top 10%). (E) Proportions of RD in groups defined by 4 risk factors (ELN-2017, complex karyotype, age, TP53 ), and the PS29MRCdic high-risk group within each risk category. The striped bar represents the high-risk category for each risk factor. adv, adverse risk; fav, favorable risk; int, intermediate risk; KT, karyotype; mut, mutated, wt, wild-type.